Navigation Links
The Max Cure Foundation Announces Its First Charity Benefit: The 'Roar for a Cure' Carnival to Be Held on Saturday, August 22, 2009
Date:7/8/2009

East Hampton Carnival And Family Fun Day Features Celebrity Guests And A Live Performance By Pop Music Group Push Play

Event Proceeds To Benefit Three Cancer Causes: The Max Cure Fund, Katy's Courage Fund And The T.J. Martell Foundation

EAST HAMPTON, N.Y., July 8 /PRNewswire-USNewswire/ -- The Max Cure Foundation -- a non-profit organization whose mission is to fund pediatric cancer causes -- announced today its first charity benefit, the first annual "Roar for a Cure" Carnival and family fun day, to take place on Saturday, August 22, from 2:00 - 6:00 p.m. (rain date: Sunday, August 23) on the grounds of the East Hampton Indoor Tennis Club, 175 Daniels Hole Road, East Hampton, N.Y. The outdoor event will have fun-filled activities for adults and kids of all ages. Highlights include: games; inflatables; prizes; food and beverages; raffles; auctions; face painting; balloon artists; gift bags; celebrity guests (to be announced); a live performance by pop music sensation Push Play; and more.

Push Play, one of the hottest new music groups in the area who consistently pack venues, will preview songs from "Found," their forthcoming album.

Tickets to the "Roar for a Cure" Carnival may be purchased in advance through The Max Cure Foundation website (www.maxcurefoundation.org) or by phone: 631-949-4160. Proceeds from the event will benefit The Max Cure Fund For Pediatric Cancer Research at Memorial Sloan-Kettering Cancer Center, dedicated to researching pediatric cancers, improving treatments and finding cures that will save children's lives; The T.J. Martell Foundation, for Leukemia, Cancer and AIDS research; and Katy's Courage Fund, which financially assists in the care of 10-year-old Katy Stewart from Sag Harbor, N.Y., as she and her family battle her rare form of liver cancer.

"On behalf of my son Max, my family and The Max Cure Foundation, we are thrilled to announce our first benefit event, the 'Roar for a Cure' Carnival and family fun day," said David Plotkin, president of The Max Cure Foundation. "It is certain to be an exciting and memorable afternoon that will be benefiting three very worthwhile causes."

A "Family Package" admits a family of four for $200; adult tickets are $100 each. The admission price includes unlimited food and drinks, all carnival activities, the Push Play concert and parking. A significant portion of the ticket price and event contributions will be tax deductible. Additional information about the event is available at The Max Cure Foundation website (www.maxcurefoundation.org).

The "Roar for a Cure" Carnival brings together the efforts of two New York-area families valiantly fighting pediatric cancer, the Plotkins and the Stewarts. Six-year-old Max Plotkin, from Manhattan and Amagansett, is the inspiration behind both The Max Cure Foundation and The Max Cure Fund. Diagnosed with an extremely rare form of B-cell Lymphoma two years ago, Max continues to hold his cancer at bay with strength beyond his years. Ten-year-old Katy Stewart, from Sag Harbor, learned that she has a rare and potentially lethal form of liver cancer earlier this year. Both children are receiving care at Memorial Sloan-Kettering Cancer Center in New York City.

ABOUT THE MAX CURE FOUNDATION

The Max Cure Foundation is a non-profit organization founded in 2008 whose mission is to fund pediatric cancer causes. The Foundation was established by the Plotkin family in honor of Maxwell Grant Plotkin, who, in May 2007 at age four, was diagnosed with an extremely rare form of B-cell Lymphoma and continues to bravely fight his disease and inspire others to rise above adversity. For more information about The Max Cure Foundation, go to: www.maxcurefoundation.org.

ABOUT THE MAX CURE FUND FOR PEDIATRIC CANCER RESEARCH

The Max Cure Fund For Pediatric Cancer Research, at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City, is dedicated to researching pediatric cancers, improving treatments and finding cures that will save children's lives. The primary mission of The Max Cure Fund is to raise $5 million to underwrite the establishment of a research laboratory at MSKCC in the Department of Pediatrics. The lab will be devoted to researching, treating and curing childhood cancers. The Max Cure Fund was established in June 2007 by the Plotkin family, in honor of Maxwell Grant Plotkin, who was diagnosed with cancer on May 2, 2007 -- one day before his fourth birthday. Eight days later, they learned Max's cancer was an extremely rare form of B-Cell Lymphoma. It is every parent's worst nightmare. Max's cancer was so rare that doctors at MSKCC, one of the premier cancer treatment facilities in the world, had never seen it before. To complicate matters, it wasn't a straight-forward case. The cancer had spread and the oncologists were blunt. Without the proper immediate treatment, the consequences would be devastating. Without delay, Max started a two-year protocol of intense chemotherapy at MSKCC, where he continues in its care and where Max's family founded The Max Cure Fund. The Max Cure Fund For Pediatric Cancer Research has already raised hundreds of thousands of dollars towards its goal and has been honored by organizations including Memorial Sloan-Kettering Cancer Center and The New York Rangers at Madison Square Garden. For more information about The Max Cure Fund, visit: www.maxcurefund.org.

ABOUT MEMORIAL SLOAN-KETTERING CANCER CENTER

Memorial Sloan-Kettering Cancer Center is the world's oldest and largest private institution devoted to prevention, patient care, research and education in cancer. Its scientists and clinicians generate innovative approaches to better understand, diagnose and treat cancer. Its specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide. For more information, go to: www.mskcc.org.

ABOUT KATY'S COURAGE FUND

Katy Stewart is ten years old and lives with her family in Sag Harbor, N.Y. She is the daughter of two Eastern Long Island educators -- Jim, a teacher and wrestling, soccer and tennis coach at East Hampton High School; and Brigid, assistant principal at Montauk Public School. Their lives were forever changed on the night of April 3, 2009, when Katy awoke at a slumber party with excruciating stomach pains. She was raced to the emergency room at Southampton Hospital. By late morning, she and her family were on their way to Stony Brook Hospital where she had a CAT scan. The scan revealed a tumor on her liver. Biopsy results were reported one week later -- the tumor was malignant. She had Hepatoblastoma, a rare liver cancer. Katy is currently undergoing treatment at Memorial Sloan-Kettering Cancer Center in New York City, where she is courageously fighting her cancer. The mission of Katy's Courage Fund is to assist the Stewart family with their financial needs while caring for Katy as the family and Katy jointly battle this potentially lethal disease.

ABOUT THE T.J. MARTELL FOUNDATION

The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research was founded in 1975 by music industry executive Tony Martell and his colleagues, in loving memory of his son, T.J., who died of leukemia. It is dedicated to raising funds for the innovative initial and ongoing research for improved treatments and cures for leukemia, cancer and AIDS. The Foundation has provided over $225 million dollars for research through a variety of events including concerts, gala awards dinners, family day activities, golf tournaments, wine dinners, and walk-a-thons. Research facilities funded by the foundation include T.J. Martell Memorial Laboratories at Mt. Sinai Medical Center in New York City, Children's Hospital Los Angeles, Frances Williams Preston Laboratories at the Vanderbilt-Ingram Cancer Center in Nashville, Columbia-Presbyterian Cancer Center, Massachusetts General Cancer Center and The Mayo Clinic. This year marks the 34th anniversary for the T.J. Martell Foundation. For more information on T.J. Martell Foundation events or the foundation in general, please view: www.TJMartellFoundation.org.

ABOUT PUSH PLAY

Pop rock band Push Play, from Long Island, N.Y., is quickly becoming one of the music industry's most sought-after talents. Push Play's online presence and their recent U.S. tour stops have brought them fervent fans throughout the country. The band's colorful edge has made them a household name in the New York area, where they routinely sell out their shows. Push Play have been featured in publications including The New York Times, Newsday, Tiger Beat, J-14 and Pop Star! magazine and have appeared on MTV's TRL and in the Macy's Thanksgiving Day Parade. They have performed in concert with Miley Cyrus and alongside such groups as No Doubt and Fall Out Boy. Their MySpace page (www.myspace.com/pushplayrox) has received over five million plays and as many profile views to date and their first single off their new album Midnight Romeo is already playing on national radio. Push Play's next album, Found, is due out in late September 2009.

SOURCE The Max Cure Foundation


'/>"/>
SOURCE The Max Cure Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Reliv Foundation Builds Feeding Center and School for Impoverished People in Haiti
2. Hospice Foundation of America Presents New Educational Webinar on SUPPORTING PEOPLE WITH INTELLECTUAL DISABILITIES THROUGH ILLNESS, GRIEF AND LOSS
3. Parents Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap
4. Jim Kerwin of Oxford Communications Donates $12,500 to the Bermuda Health Foundation Salute to Service Awards Luncheon
5. Foundation Radiology Group Receives First-Ever National Accreditation
6. The Psychology of Frailty: An Identity Crisis Among the Elderly - Alzheimers Drug Discovery Foundations Dr. Howard Fillit to Co-Chair Symposium
7. Tiger Woods, Camilo Villegas & Mike Weir to Play at Notah Begay III Foundation Challenge to Benefit Native American Youth
8. Online Voting Begins for Ford Customer Service Divisions Second Annual Funny Car Design Contest to Support Juvenile Diabetes Research Foundation
9. Oral Cancer Foundation Praised for Its Social Media Efforts
10. Newly Launched Free Choice Foundation Attempts Rescue of Japan's Private Heath Care Network
11. Beryl Receives Entrepreneurs Foundation of North Texas North Star Recognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Dennis Thompson ... News) -- Babies born prematurely appear to have a ... they will carry into adulthood, Swedish researchers report. ... 37 weeks, gestation have a raised risk of deep ... by blood clotting in the veins, the researchers noted ...
(Date:7/28/2014)... A new study, published in the July, 2014, ... Cancer Institute by Northwestern Medicine researchers, sheds ... growing popularity of endoscopic resection in the treatment ... the more traditional surgical resection, while more invasive, ... five-year survival rate for patients than endoscopic resection, ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 A young ... to the all-too-often stories in the media today about ... occur in a matter of minutes in a hot ... to the Office of Emergency Medical Services at NHTSA. ... app for smartphones. Realizing that it’s all too easy ...
(Date:7/28/2014)... Irresistible infants have met their match with a darling ... gifting company specializes in homemade chicken noodle soup and creates bundles ... starts with home-from-the-hospital essentials every new parent will love:, ... , 6 cookies , a ladle to ... to heat and eat upon delivery, so parents can relax and ...
(Date:7/28/2014)... Albany, New York (PRWEB) July 28, 2014 ... Transparency Market Research "E-Clinical Solution Software Market- Global Industry ... 2020," the global microfluidic device market was valued at ... grow at a CAGR of 13.8% from 2014 to ... million in 2020. , Globally, the e-clinical solution software ...
Breaking Medicine News(10 mins):Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 2Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 3Health News:Study helps compare risks of treatments for early esophageal cancer 2Health News:Study helps compare risks of treatments for early esophageal cancer 3Health News:'Precious Cargo' App Released to Help Save Babies from the Dangers of Being Accidentally Left Behind in Hot Cars 2Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4
... Stereotaxis, Inc.,(Nasdaq: STXS ) today announced ... institutional investors to raise gross proceeds of $20,million through ... separate,concurrent transactions. A portion of the warrants sold will ... warrants would provide an additional,approximately $10 million in gross ...
... about possible outcomes, study finds , , MONDAY, Dec. 29 ... ill patients want doctors to frankly discuss the patient,s prognosis ... , The University of San Francisco Medical Center study, ... Journal of Respiratory and Critical Care Medicine , points out ...
... Calif., Dec. 29 Accuray Incorporated (Nasdaq: ... radiosurgery, announced today that its management is scheduled to ... in New York, on Wednesday, January 7, 2009 at ... the presentation will be available online from the investor ...
... LCAV ) Board of Directors strongly opposes the consent ... that the Company has undertaken a prudent and achievable strategic ... Joffe intervention is a poorly designed effort to take control ... Joffe effort is an undue distraction to the Company that ...
... Directory on Internet - , , ANTHEM, Ariz., ... announced launch of its new web site at http://www.mychoicedentist.com ... in the Phoenix , Arizona, area is proceeding successfully. ... Chris Theotocatos, CEO. "We anticipate expanding this service to almost ...
... Plans New Products and Expanded Services in 2009 , ... ... has reported its seventh consecutive year of revenue growth in 2008, ... demand for media relations and marketing services provided by its HRmarketer ...
Cached Medicine News:Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 2Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 3Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 4Health News:Family Needs to Know When Patient Survival Is Uncertain 2Health News:Accuray Incorporated to Present at 11th Annual Needham Growth Stock Conference 2Health News:LCA-Vision Urges Stockholders to Take No Action Regarding the Joffe Group's Threatened Consent Solicitation 2Health News:Prime Companies Announces Launch of New Dental Web Site 2Health News:Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability 2Health News:Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability 3
(Date:7/28/2014)... Colo. , July 28, 2014  Array ... financial results for the fourth quarter and ... a conference call to discuss those results ... Chief Executive Officer and Michael Carruthers ... call.Conference Call InformationDate:Tuesday, August 12, 2014Time:9:00 a.m. ...
(Date:7/28/2014)... 28, 2014  Syneron Medical Ltd. (NASDAQ: ... today that its new PicoWay® device has received CE ... colors and pigmented lesions on any skin type. PicoWay ... 532nm and 1064nm wavelengths, which utilizes Syneron,s proprietary PicoWay ... which are trillionths of a second, known as picosecond ...
(Date:7/28/2014)... July 28, 2014  ResMed (NYSE: RMD ... the treatment of sleep-disordered breathing and other chronic respiratory ... Germany against Taiwanese medical device manufacturer APEX ... on APEX WiZARD 210 and 220 masks.  The judgment ... Munich , is appealable, and applies throughout ...
Breaking Medicine Technology:Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
... 2011 K-V Pharmaceutical Company (the "Company") (NYSE: ... of Obstetricians and Gynecologists (ACOG) and Society for ... and ensure that healthcare providers, patients, and the ...  The information update from ACOG and SMFM confirms ...
... MONTREAL, Oct. 13, 2011 A Medco Health Solutions, ... found that 38 percent of patients prescribed Plavix® (clopidogrel)—an ... and stroke—were also using another drug that would impede ... The analysis also showed that primary care physicians ...
Cached Medicine Technology:K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 2K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 3K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 4K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 5K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 6K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 7K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 8Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 2Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 3Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 4
The all silicone construction of the shaft and neck flange provides the utmost in patient comfort. , ,The Aire-Cuf® tracheostomy tube offers a more traditional and familiar air-filled cuff desig...
... ISO termination for easy ventilator circuit attachment ... , ,Clearly the softer choice in ... ,The Portex® flexible disposable inner cannula ... chloride, providing a softer and more pliable ...
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions...
... Adult TRACH CARE Dual Lumen, ... at the patient end of ... Double Swivel Elbow and Direction ... port. Offers multiple tracheostomy sizes, ...
Medicine Products: